S. Korea Postpones Moving Anti-Contraception Drugs To OTC Status
This article was originally published in PharmAsia News
Executive Summary
South Korean health officials reversed themselves and decided on at least a three-year delay in allowing birth control and morning-after abortion drugs to be sold over the counter.